Clinical Trials Browser

Phase 2 × Leukemia, Myeloid × lestaurtinib × Clear all

NCT00030186 2012-08-23

Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid